CN109355366A - HLA-B high-resolution gene sequencing kit - Google Patents

HLA-B high-resolution gene sequencing kit Download PDF

Info

Publication number
CN109355366A
CN109355366A CN201811597486.6A CN201811597486A CN109355366A CN 109355366 A CN109355366 A CN 109355366A CN 201811597486 A CN201811597486 A CN 201811597486A CN 109355366 A CN109355366 A CN 109355366A
Authority
CN
China
Prior art keywords
hla
sequencing
seq
gene
amplification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201811597486.6A
Other languages
Chinese (zh)
Inventor
王林林
张倩
周云丽
刘克瑶
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Yinfeng Gene Technology Co Ltd
Yinfeng Biological Group Ltd
Original Assignee
Yinfeng Gene Technology Co Ltd
Yinfeng Biological Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yinfeng Gene Technology Co Ltd, Yinfeng Biological Group Ltd filed Critical Yinfeng Gene Technology Co Ltd
Priority to CN201811597486.6A priority Critical patent/CN109355366A/en
Publication of CN109355366A publication Critical patent/CN109355366A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6869Methods for sequencing
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/156Polymorphic or mutational markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

The invention discloses HLA-B high-resolution gene sequencing kits, including 1 pair of amplimer, as shown in SEQ ID NO.1,2, and for 5 sequencing primers of sequencing, as shown in NO.3~7 SEQ ID.The invention also discloses the detection methods of HLA-B Genotyping: carrying out PCR amplification using amplimer shown in SEQ ID NO.1,2, is then sequenced using sequencing primer shown in NO.3~7 SEQ ID, so that it is determined that the type of HLA gene.2,3,4 exons are sequenced in kit and method of the invention, can also carry out supplement sequencing, genotyping result combined few to 1,5 exons when necessary.Accurate parting can be carried out to the site B overall length, a generation and two generation microarray datasets can be annexed, main agents voluntarily can configure and optimize in HLA gene sequencing kit, and the reagent cost substantially reduced simultaneously, improves the accuracy rate of parting.

Description

HLA-B high-resolution gene sequencing kit
Technical field
The present invention relates to a kind of HLA-B high-resolution gene sequencing kits, belong to technical field of gene detection.
Background technique
Major histocompatibility complex (MHC) is also known as human leukocyte antigen (HLA), is the something lost of most complex human Pass polymorphism system.HLA gene is located on No. 6 the short arm of a chromosome 6p21.31 of people, the HLA-I class molecule and HLA- of coding II class molecule plays a significant role in regulation immune response, decision disease susceptibility.
According to the function of the product of gene loci and they, HLA can be divided into: class Ⅰ antigens: the production in the site HLA-A, B, C Object, class Ⅱ antigens: the product in the site HLA-DR, DQ, DP, three classes antigen: the complement components such as C4A, C4B, C2, Bf composition.It is polymorphic Property is the important feature of HLA, ends in May, 2018, international immunogenetics database (IMGT, http: // Www.ebi.ac.uk/ipd/imgt/hla/ 18181 kinds of HLA allele) are disclosed, wherein I class and class Ⅱ antigens and transplanting It is closely related.
Accurate HLA typing method and typing data have been widely used in finding in organ and hematopoietic stem cell transplantation Donor, HLA and disease associated research, parenthood determination, individual identification and the disease based on peptide that HLA matches The application fields such as the research and development of poison and cancer vaccine.The degree of cooperation of HLA allele and transplantation effect are closely related between donor-recipient, Accurate HLA parting helps to improve the survival rate after transplanting.
The HLA typing method of international standard has PCR-SSP (sequence specific primers polymerase chain reaction), PCR- at present SSO (hybridization of polymerase chain reaction oligonucleotide probe) and PCR-SBT (sequence-based typing method).The principle of SSO method It is to design the special oligonucleotide sequence of HLA gene type as probe, PCR product is marked, with PCR product and probe Hybridized, judges gene type by detecting signal.SSP method needs to design a whole set of gene-specific primer, passes through PCR Technology obtains specific product, determines gene type by electrophoretic analysis.PCR-SBT is that direct Sequencing analysis base is carried out to DNA Because of classifying method, it is the experimental method for the high-resolution level HLA Genotyping that WHO recommends, DNA sequence dna can be directly obtained, identifies All existing polymorphisms, for most direct, most intuitive method.
Sequencing based type (PCR-SBT), is current HLA high-resolution genotyping " goldstandard ", and SBT method is divided into generation survey Sequence and two generations sequencing (Next Generation sequencing, NGS).PCR-SBT has result accurate and the degree of automation The advantages that high, can be carried out recognition sequence and parting, be even more to have unique advantage in terms of finding new allele.A generation is surveyed It has been a very mature method so far that sequence method was born from 1977, and the sequencing of two generations is sequenced relative to a generation carries out HLA points Type has the characteristics that high throughput, easily automates, reduces equivocal result.Routinely sequencing has the HLA-B gene of generation sequencing at present 2,3,4 exon.
Summary of the invention
For the above-mentioned prior art, the present invention provides a kind of HLA-B high-resolution gene sequencing kits, can answer simultaneously With in generation sequencing and two generations sequencing Illumina platform, in control cost, it is all advantageous to improve typing resolution etc..
The present invention is achieved by the following technical solutions:
HLA-B high-resolution gene sequencing kit, (can including 1 pair of amplimer for expanding HLA-B full length gene 1,2,3,4,5,6,7 exons of HLA-B are expanded, include full exon, amplification length 2.8K), and for HLA-B base to be sequenced Because of 5 sequencing primers of 2,3,4 exons, wherein the nucleotide sequence of 1 pair of amplimer is as follows:
AmpB-F:5'-TGTCGGGACCTTCTTCA-3';As shown in SEQ ID NO.1;
AmpB-R:5'-AYAGACTCAGCACAGCGAAC-3';(annexing base Y-TC) is as shown in SEQ ID NO.2;
The nucleotide sequence of 5 sequencing primers is as follows:
SeqB2F:5'-GAGCGCACCGCTGGCG-3';As shown in SEQ ID NO.3;
SeqB2R:5'-TGGGGTGTCGTGACCTG-3';As shown in SEQ ID NO.4;
SeqB3F:5'-GGGGGCAGGGACACAC-3';As shown in SEQ ID NO.5;
SeqB3R:5'-TTTCGTCCTCTTCTCGTTG-3';As shown in SEQ ID NO.6;
SeqB4F:5'-CTCACGCTCTCACATGG-3';As shown in SEQ ID NO.7.
Wherein, be sequenced 2 exons primer be seqB2F, seqB2R, sequencing 3 exons sequencing primer be seqB3F, SeqB3R, the sequencing primer of 4 exons of sequencing are seqB4F.
Further, the HLA-B high-resolution gene sequencing kit is made of amplification part and sequencing part, amplification portion Dividing includes following components: PCR buffer (contains Mg2+), dNTP Mix, Taq enzyme and amplimer ampB-F and ampB-R;Taq enzyme Select TAKARA LA Taq;Sequencing part includes following components: BigDye v3.1, BigDye v3.1Buffer, sequencing primer SeqB2F, seqB2R, seqB3F, seqB3R, seqB4F.
The detection method of HLA-B Genotyping, comprising the following steps:
(1) sample gene to be tested group DNA is extracted according to routine techniques;
(2) above-mentioned amplimer (ampB-F and ampB-R) is utilized, PCR amplification is carried out to sample to be tested genomic DNA, is obtained To the amplified production containing HLA-B full length gene;
(3) to amplified production electrophoresis: 250V, 10min, and purified using exonuclease and shrimp alkaline phosphotase;
(4) PCR product after purification, using above-mentioned sequencing primer (seqB2F, seqB2R, seqB3F, seqB3R, SeqB4F 2,3,4 exons) are sequenced respectively, obtain sequencing product;
(5) product denaturation, purifying, the sequencing of upper machine will be sequenced, obtain sequencing result;
(6) the exon standard sequence of sequencing result and the HLA gene in database is compared, determines HLA gene Type.
Further, in the step (2) PCR amplification reaction condition are as follows: 96 DEG C, 2min;98 DEG C, 10s → 65 DEG C, 50s → 72 DEG C, 3min (30 circulations);72 DEG C, 5min;4 DEG C of holdings.
Further, the reaction condition being sequenced in the step (4) are as follows: 96 DEG C, 10s;96 DEG C, 10s → 50 DEG C, 10s → 60 DEG C, 2min (25 circulations);12 DEG C of holdings.
Basic principle of the invention is: the polymorphism of HLA is complicated, about 5212, HLA-B allele, therefore, to have The PCR primer that can expand the site HLA-B overall length is designed in the conservative region of limit, and for the redesign sequencing of 2,3,4 exons Primer.The design of primers template of HLA-B is B*07:02:01:01 genotype, and allelic sequences are referring to Europe IMGT/HLA Professional website data: http://www.ebi.ac.uk/imgt/hla/index.html.
The technology of the present invention advantage: 2,3,4 exons are sequenced in the present invention, can also carry out when necessary to 1,5 exons Supplement sequencing, genotyping result combined few.Amplification system of the present invention carries out stability verifying in two generation microarray datasets simultaneously, can be right The site B overall length carries out accurate parting, since the present invention can annex a generation and two generation microarray datasets, in HLA gene sequencing kit Main agents voluntarily can configure and optimize, and the reagent cost substantially reduced simultaneously, improves the accuracy rate of parting.
The various terms and phrase that the present invention uses are with well known to a person skilled in the art general senses.
Detailed description of the invention
Fig. 1: amplified sample electrophoretogram.
Peak figure is sequenced in the site Fig. 2: B.
Specific embodiment
Below with reference to embodiment, the present invention is further illustrated.However, the scope of the present invention is not limited to following realities Apply example.One of skill in the art, can be to the present invention it is understood that under the premise of without departing substantially from the spirit and scope of the present invention Carry out various change and modification.
Instrument involved in following embodiments, reagent, material etc. are unless otherwise noted existing in the prior art Conventional instrument, reagent, material etc., can be obtained by regular commercial sources.Experimental method involved in following embodiments, inspection Survey method etc. is unless otherwise noted existing routine experiment method in the prior art, detection method etc..
The design and screening of 1 primer of embodiment
8 pairs of amplimers (as shown in table 1) are devised using Primer Premier5,21 sequencing primers are (such as 2 institute of table Show).
Using the 8 pairs of amplimers designed, to known type, very this is expanded, (concrete operations of amplification refer to electrophoresis Concrete operations in following application examples), and electrophoresis result is observed and recorded, the results are shown in Table 1.As shown in Table 1, first pair, Second pair of amplimer, electrophoretic effects are good (electrophoretic band is single, no disperse), other 6 pairs of amplimers it is ineffective, because This, selects these two pair amplimer to carry out next step experiment.
After obtaining amplified production using above-mentioned two pairs of amplimers, using the sequencing primer in table 2, to 2,3,4 exons Both-end sequencing (concrete operations of survey are with reference to the concrete operations in following application examples) are carried out respectively, obtain sequencing peak figure, observation is simultaneously The superiority and inferiority of record sequencing peak figure, the results are shown in Table 2.As shown in Table 2, in 2 exon forward direction sequencing primers, the 4th article of primer The effect of (shown in SEQ ID NO.3) is best, other 3 primers it is ineffective, therefore, select this primer as the present invention HLA-DQB1 genotyping kit sequencing primer.Similarly, other several sequencing primers are screened, it is final to determine, SEQ ID NO.1, amplimer shown in 2, sequencing primer shown in SEQ ID NO.3,4,5,6,7 is as HLA- of the invention The sequencing primer of B high-resolution gene sequencing kit.
1 amplified production of table
2 sequencing primer of table
Application example carries out the hrr gene parting in the site HLA-B to human blood sample
Specific step is as follows:
(1) it extracts genomic DNA: being stripped according to Tiangeng company genome DNA extraction kit operational manual.
(2) PCR amplification: genomic DNA is expanded using amplimer.Use the site HLA-B amplimer (SEQ ID No.1, SEQ ID No.2) amplification of HLA-B parting is carried out, amplification program and amplification reaction system be as follows:
Pcr amplification reaction condition are as follows: 96 DEG C, 2min;98 DEG C, 10s → 65 DEG C, 50s → 72 DEG C, 3min (30 circulations); 72 DEG C, 5min;4 DEG C of holdings.
PCR reaction system is 20 μ l, and composition is as shown in table 3.
Table 3
10×LA Buffer(Mg2+) 2μl
dNTP(2.5mM) 1.6μl
F(10pM) 0.5μl
R(10pM) 0.5μl
ddH2O 13.2μl
LATaq 0.2μl
DNA(30ng/μl) 2μl
Wherein, 10 × LA Buffer (Mg2+), dNTP (2.5mM), LATaq archaeal dna polymerase be purchased from Bao Sheng biotech firm, Primer is purchased from Invitrogen.The electrophoretogram of amplification gained PCR product is as shown in Figure 1, the results showed that obtains target gene fragment.
(3) amplified production is purified using exonuclease and shrimp alkaline phosphotase.
(4) sequencing amplification is carried out using sequencing primer: using sequencing primer (SEQ ID No.3~SEQ ID No.7) point Other that the 2nd of HLA-B amplified production, 3,4 exons are sequenced, sequencing procedure and sequencing reaction system are as follows:
Sequencing reaction condition are as follows: 96 DEG C, 10s;96 DEG C, 10s → 50 DEG C, 10s → 60 DEG C, 2min (25 circulations);12℃ It keeps.
Sequencing reaction system is 10 μ l, and composition is as shown in table 4.
Table 4
BigDye v3.1 0.25μl
BigDye v3.1Buffer 1.9μl
Primer (10pM) 1μl
ddH2O 5.85μl
Amplification purification product 1μl
Wherein, Bigdye v3.1 is purchased from ABI company.
Conventionally sequencing product is purified.
(5) it carries out exon sequencing: machine on sequencing product after purification being sequenced using 3730 sequenator of ABI company, survey Sequence result is as shown in Fig. 2, sequencing peak figure can recognize phenomenon invariably, and peak figure wave mode is uniform, no miscellaneous peak, and heterozygosis peak dispersion rate is 50% Left and right, whole peak figure is clear, leakless type.
Above-described embodiment is provided to those skilled in the art, how to implement and use to be advocated with full disclosure and description Embodiment, rather than for limiting range disclosed herein.Obvious modification will to those skilled in the art Within the scope of the appended claims.
Sequence table
<110>Yin Feng Gene Tech. Company Limited
Yinfeng Bioengineering Group Co., Ltd.
<120>HLA-B high-resolution gene sequencing kit
<141> 2018-12-26
<160> 7
<170> SIPOSequenceListing 1.0
<210> 1
<211> 17
<212> DNA
<213> Artificial Sequence
<400> 1
tgtcgggacc ttcttca 17
<210> 2
<211> 20
<212> DNA
<213> Artificial Sequence
<400> 2
ayagactcag cacagcgaac 20
<210> 3
<211> 16
<212> DNA
<213> Artificial Sequence
<400> 3
gagcgcaccg ctggcg 16
<210> 4
<211> 17
<212> DNA
<213> Artificial Sequence
<400> 4
tggggtgtcg tgacctg 17
<210> 5
<211> 16
<212> DNA
<213> Artificial Sequence
<400> 5
gggggcaggg acacac 16
<210> 6
<211> 19
<212> DNA
<213> Artificial Sequence
<400> 6
tttcgtcctc ttctcgttg 19
<210> 7
<211> 17
<212> DNA
<213> Artificial Sequence
<400> 7
ctcacgctct cacatgg 17

Claims (6)

1.HLA-B high-resolution gene sequencing kit, it is characterised in that: including 1 pair of amplification for expanding HLA-B full length gene Primer, and 5 sequencing primers for 2,3,4 exon of HLA-B gene to be sequenced, wherein the nucleotides sequence of 1 pair of amplimer Column are as follows:
AmpB-F:5'-TGTCGGGACCTTCTTCA-3';As shown in SEQ ID NO.1;
AmpB-R:5'-AYAGACTCAGCACAGCGAAC-3';As shown in SEQ ID NO.2;
The nucleotide sequence of 5 sequencing primers is as follows:
SeqB2F:5'-GAGCGCACCGCTGGCG-3';As shown in SEQ ID NO.3;
SeqB2R:5'-TGGGGTGTCGTGACCTG-3';As shown in SEQ ID NO.4;
SeqB3F:5'-GGGGGCAGGGACACAC-3';As shown in SEQ ID NO.5;
SeqB3R:5'-TTTCGTCCTCTTCTCGTTG-3';As shown in SEQ ID NO.6;
SeqB4F:5'-CTCACGCTCTCACATGG-3';As shown in SEQ ID NO.7.
2. HLA-B high-resolution gene sequencing kit according to claim 1, it is characterised in that: the HLA-B high-resolution Gene sequencing kit is made of amplification part and sequencing part, and amplification part includes following components: PCR buffer (contains Mg2 +), dNTP Mix, Taq enzyme and amplimer ampB-F and ampB-R;Taq enzyme selects TAKARA LA Taq;Sequencing part includes Following components: BigDye v3.1, BigDye v3.1Buffer, sequencing primer seqB2F, seqB2R, seqB3F, seqB3R, seqB4F。
3. application of the HLA-B high-resolution gene sequencing kit of any of claims 1 or 2 in detection HLA-B Genotyping.
The detection method of 4.HLA-B Genotyping, it is characterised in that: the following steps are included:
(1) sample gene to be tested group DNA is extracted according to routine techniques;
(2) using amplimer shown in SEQ ID NO.1,2, PCR amplification is carried out to sample to be tested genomic DNA, is contained There is the amplified production of HLA-B full length gene;
(3) to amplified production electrophoresis: 250V, 10min, and purified using exonuclease and shrimp alkaline phosphotase;
(4) PCR product after purification, using SEQ ID NO.3~shown in sequencing primer 2,3,4 exons are sequenced respectively, obtain To sequencing product;
(5) product denaturation, purifying, the sequencing of upper machine will be sequenced, obtain sequencing result;
(6) the exon standard sequence of sequencing result and the HLA gene in database is compared, determines the type of HLA gene Not.
5. the detection method of HLA-B Genotyping according to claim 4, it is characterised in that: PCR in the step (2) The reaction condition of amplification are as follows: 96 DEG C, 2min;98 DEG C, 10s → 65 DEG C, 50s → 72 DEG C, 3min, 30 circulations;72 DEG C, 5min;4 DEG C keep.
6. the detection method of HLA-B Genotyping according to claim 4, it is characterised in that: sequencing in the step (4) Reaction condition are as follows: 96 DEG C, 10s;96 DEG C, 10s → 50 DEG C, 10s → 60 DEG C, 2min, 25 circulations;12 DEG C of holdings.
CN201811597486.6A 2018-12-26 2018-12-26 HLA-B high-resolution gene sequencing kit Pending CN109355366A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201811597486.6A CN109355366A (en) 2018-12-26 2018-12-26 HLA-B high-resolution gene sequencing kit

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201811597486.6A CN109355366A (en) 2018-12-26 2018-12-26 HLA-B high-resolution gene sequencing kit

Publications (1)

Publication Number Publication Date
CN109355366A true CN109355366A (en) 2019-02-19

Family

ID=65329397

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201811597486.6A Pending CN109355366A (en) 2018-12-26 2018-12-26 HLA-B high-resolution gene sequencing kit

Country Status (1)

Country Link
CN (1) CN109355366A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111793681A (en) * 2020-07-31 2020-10-20 苏州大学附属第一医院 HLA-B locus allele typing kit and detection method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101892317A (en) * 2010-07-29 2010-11-24 苏州大学 HLA high-resolution gene sequencing kit
CN101928776A (en) * 2010-08-18 2010-12-29 浙江省血液中心 PCR-SBT method for HLA genotyping and reagent thereof
CN108192964A (en) * 2017-12-27 2018-06-22 银丰基因科技有限公司 HLA-C full-length gene parting kits

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101892317A (en) * 2010-07-29 2010-11-24 苏州大学 HLA high-resolution gene sequencing kit
CN101928776A (en) * 2010-08-18 2010-12-29 浙江省血液中心 PCR-SBT method for HLA genotyping and reagent thereof
CN108192964A (en) * 2017-12-27 2018-06-22 银丰基因科技有限公司 HLA-C full-length gene parting kits

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
YAYI HE ET AL.: "Association of HLA-B and HLA-DRB1 polymorphisms with antithyroid drug-induced agranulocytosis in a Han population from northern China", 《SCIENTIFIC REPROTS》 *
何华庆 等: "江西地区强直性脊柱炎患者HLA-B27基因PCR-SBT分型研究", 《实验与检验医学》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111793681A (en) * 2020-07-31 2020-10-20 苏州大学附属第一医院 HLA-B locus allele typing kit and detection method thereof
CN111793681B (en) * 2020-07-31 2023-08-25 苏州大学附属第一医院 HLA-B locus allele typing kit and detection method thereof

Similar Documents

Publication Publication Date Title
US5578443A (en) DNA sequence-based HLA typing method
JPH06505391A (en) HLA typing based on DNA sequencing
CN108410866B (en) SNP marker related to high-altitude adaptability of Chinese domestic horses and application thereof
CN112048562B (en) SNP molecular marker influencing diameter of alpine merino sheep wool fiber and application thereof
CN101892317A (en) HLA high-resolution gene sequencing kit
WO2014065410A1 (en) Method and kit for dna typing of hla gene
CN110331193A (en) A kind of mankind kill the PCR-SBT method and reagent of cell immunoglobulin receptor KIR3DL2 Genotyping
CN104894230B (en) The group-specific primers PCR-SBT methods and reagent of a kind of HLA-DQB1 Genotypings
CN110541041B (en) SNP marker related to Chinese domestic horse dwarf trait and application thereof
CN101818195B (en) Genetic marker by taking pig miR-27a precursor flanking sequence SNP as trait of litter size of pig and application
CN116397032B (en) SNP molecular marker related to buffalo weight growth traits and application thereof
CN109355366A (en) HLA-B high-resolution gene sequencing kit
CN110241234B (en) Fluorescence-labeled 32-plex InDels composite amplification system and application thereof
CN114317780B (en) SNP molecular marker related to chicken prematurity and application
Oreshkova et al. Development of microsatellite genetic markers in Siberian larch (Larix sibirica Ledeb.) based on the de novo whole genome sequencing
CN106755422B (en) Detection method of MEG3 gene SNP related to cattle growth traits and application thereof
KR20160138853A (en) SNP markers for discriminating Korean Brown Cornish line of chicken and use thereof
CN110747280B (en) TE mark related to cold adaptability of horse and application thereof
KR101686443B1 (en) SNP markers for discriminating Rhode Island Red breed of chicken and use thereof
Chaves et al. Survey of a cDNA library from the turkey (Meleagris gallopavo)
KR101985659B1 (en) Method for identification of Baekwoo breed using single nucleotide polymorphism markers
CN112746100A (en) Primer, kit and method for KIR genotyping
KR101854896B1 (en) Single nucleotide polymorphism markers for identifying korean traditional dog breeds and uses thereof
CN109355367A (en) The detection method of the common equivocal type in the site HLA parting A
CN114622020B (en) KLHL31 gene molecular marker related to chicken growth traits and application thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
CB03 Change of inventor or designer information

Inventor after: Wang Linlin

Inventor after: Zhang Qian

Inventor after: Si Meng

Inventor after: Zhou Yunli

Inventor after: Liu Keyao

Inventor before: Wang Linlin

Inventor before: Zhang Qian

Inventor before: Zhou Yunli

Inventor before: Liu Keyao

CB03 Change of inventor or designer information
RJ01 Rejection of invention patent application after publication

Application publication date: 20190219

RJ01 Rejection of invention patent application after publication